Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong maintains an Overweight rating on iRhythm Technologies (NASDAQ:IRTC) but lowers the price target from $135 to $130.
July 15, 2024 | 5:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on iRhythm Technologies but lowers the price target from $135 to $130.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100